Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Liminatus Pharma, Inc. Class A Common Stock
Market Cap
$4.97M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$4.86M
Net Profit Margin
-75.90%
TTM Avg
-124.23%
3Y Avg
-198.78%
5Y Avg
-629.10%
Market Cap
$5.12M
Net Profit Margin
-612568.11%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.21M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.21M
Net Profit Margin
-106.78%
TTM Avg
-43.08%
3Y Avg
-12.30%
5Y Avg
-12.30%
Market Cap
$4.72M
Net Profit Margin
-118.27%
TTM Avg
-13237.88%
3Y Avg
-7961.50%
5Y Avg
-5307.67%
Market Cap
$5.22M
Net Profit Margin
0.00%
TTM Avg
-61.23%
3Y Avg
-156.55%
5Y Avg
-194.88%
Market Cap
$4.71M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1794.91%
5Y Avg
-2605.04%
Market Cap
$5.24M
Net Profit Margin
-294.91%
TTM Avg
-320.57%
3Y Avg
-453.36%
5Y Avg
-361.46%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $4.97M | 0.00% | 0.00% | 0.00% | N/A |
| Xenetic Biosciences, Inc. (XBIO)vs › | $4.86M | -75.90% | -124.23% | -198.78% | -629.10% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.12M | -612568.11% | 0.00% | 0.00% | 0.00% |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.21M | -106.78% | -43.08% | -12.30% | -12.30% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.72M | -118.27% | -13237.88% | -7961.50% | -5307.67% |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | 0.00% | -61.23% | -156.55% | -194.88% |
| Imunon, Inc. (IMNN)vs › | $4.71M | 0.00% | 0.00% | -1794.91% | -2605.04% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | -294.91% | -320.57% | -453.36% | -361.46% |
| CalciMedica, Inc. (CALC)vs › | $4.69M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
